MARCO M. BRUGHERA, DVM

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

SOLIGENIX, INC.

Filing Date Source Excerpt
2014-05-08 Marco Brughera, DVM has been a director since October 2013. He is the Global Head of the Rare Disease Franchise for Sigma-Tau S.p.A... Compensation of Directors: Marco Brughera - Fees Earned Paid in Cash $8,750, Option Awards $30,150, Total $38,900.
2015-05-01 Marco Brughera, DVM joined the Board of Directors in October 2013. He is the Global Head of the Rare Disease Business Unit for the Sigma-Tau Group... The Compensation Committee is comprised of Dr. Rubin (Chair), Dr. Brughera and Dr. Zeldis.
2016-05-02 Marco M. Brughera, DVM joined the Board of Directors in October 2013. He is the Global Head of the Rare Disease Business Unit for Sigma Tau Finanziaria S.p.A. Group... The Compensation Committee is comprised of Dr. Rubin (Chair), Dr. Brughera and Dr. Zeldis... Compensation of Directors: Marco M. Brughera Fees Earned Paid in Cash $40,000, Option Awards $30,000, Total $70,000.
2017-04-28 Marco M. Brughera, DVM joined the Board of Directors in October 2013... The Compensation Committee is comprised of Dr. Rubin (Chair), Dr. Brughera and Dr. Zeldis... The following table contains information concerning the compensation of the non-employee directors during the fiscal year ended December 31, 2016. Marco M. Brughera Fees Earned Paid in Cash $40,000 Option Awards $30,000 Total $70,000.
2018-08-10 Marco M. Brughera, DVM 63 Director

Data sourced from SEC filings. Last updated: 2025-12-07